Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases

Gut

Volumn 40, Issue 5, 1997, Pages 591-596

  Gotz J M ^a   Thio, J L ^a   Verspaget, H W ^a   Offerhaus, G J A ^b   Biemond, I ^a   Lamers, C B H W ^a   Veenendaal, R A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antioxidants; Gastric mucosa; Gastritis; Helicobacter pylori; Reactive oxygen species; Superoxide dismutase

Indexed keywords

CLARITHROMYCIN; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA;

EID: 0030996458     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.5.591     Document Type: Article

References (35)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-5.
2. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori induced inflammation. Gastroenterology 1992; 102: 720-7.
3. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991; 13: 42-59.
4. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
5. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992; 52: 6735-40.
6. Anonymous. Schistosomes, liver flukes, and Helicobacter pylori. IARC working group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241.
7. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
8. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Clin Lab Med 1992; 119: 598-620.
9. Davies GR, Rampton DS. Helicobacter pylori, free radicals, and gastro-duodenal disease. Eur J Gastroenterol Hepatol 1994; 6: 1-10.
10. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993; 49: 481-93.
11. Niida H, Okada M, Takeuchi K, Okabe S. A new model of duodenal ulcers induced in rats by diethyldithiocarbamate, a superoxide dismutase inhibitor. Scand J Gastroenterol 1989; 24 (suppl 162): 116-9.
12. Verspaget HW, Mulder TPJ, van der Sluys Veer A, Peña AS, Lamers CBHW. Reactive oxygen metabolites and colitis; a disturbed balance between damage and protection. Scand J Gastroenterol 1991; 26 (suppl 188): 44-51.
13. Nielsen H, Andersen LP. Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology 1992; 103: 1747-53.
14. Davies GR, Simmonds NJ, Stevens TRJ, Sheaff MT, Banatvala N, Laurenson IF, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-85.
15. de Groot H. Reactive oxygen species in tissue injury. Hepatogastroenterology 1994; 41: 328-32.
16. Smith SM, Kvietys PR. Gastric ulcers: role of oxygen radicals. Crit Care Med 1988; 16: 892-8.
17. Ogino K, Oka S, Okazaki Y, Takemoto T. Gastric mucosal protection and superoxide dismutase. J Clin Gastroenterol 1988; 10 (suppl 1): S129-32.
18. Götz JM, van Kan CI, Verspaget HW, Biemond I, Lamers CBHW, Veenendaal RA. Gastric mucosal superoxide dismutases in Helicobacter pylori infection. Gut 1996; 38: 502-6.
19. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.
20. Veenendaal RA, Lichtendahl-Bernards AT, Peña AS, Endtz HPh, van Boven CPA, Lamers CBHW. Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens. J Clin Pathol 1993; 46: 561-3.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
22. Mulder TPJ, Verspaget HW, Janssens AR, De Bruin PAF, Peña AS, Lamers CBHW. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 1991; 32: 1146-50.
23. Beyer W, Imlay J, Fridovich I. Superoxide dismutases. Prog Nucleic Acid Res Mol Biol 1991; 40: 221-53.
24. Kozol R, Kopatzis A, Fligiel SEG, Czanko R, Callewaert D. Neutrophil-mediated injury to gastric mucosal surface cells. Dig Dis Sci 1994; 34: 138-14.
25. Spiegelhalder C, Gerstenecker B, Kersten A, Schiltz E, Kist M. Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Infect Immun 1993; 61: 5315-25.
26. Michetti P, Wadström T, Kraehenbuhl J-P, Lee A, Kreiss C, Blum AL. Frontiers in Helicobacter pylori research: pathogenesis, host response, vaccine development, and new therapeutic approaches. Eur J Gastroenterol Hepatol 1996; 8: 717-22.
27. Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. J Biol Chem 1990; 265: 2856-64.
28. Kawaguchi T, Suzuki KC, Matsuda Y, Nishiura T, Uda T, Ono M, et al. Serum manganese superoxide dismutase: normal values and increased levels in patients with acute myocardial infarction and several malignant diseases determined by an enzyme-linked immunosorbent assay using a monoclonal antibody. J Immunol Methods 1990; 127: 249-54.
29. Janssen AML, Bosman CB, Sier CFM, Griffioen G, Lamers CBHW, Verspaget HW. Levels and relation with clinical outcome of superoxide dismutases in colorectal neoplasia. Proc Am Assoc Cancer Res 1996; 37: 194.
30. Götz JM, Vergouwe Y, Verspaget HW, Biemund I, Sier CFM, Lamers CBHW, et al. Gastric mucosal plasminogen activators in Helicobacter pylori infection. Dig Dis Sci 1996; 41: 1577-82.
31. Götz JM, Ravensbergen JW, Verspaget HW, Biemond I, Sier CFM, Offerhaus GJA, et al. The effect of treatment of Helicobacter pylori on gastric mucosal plasminogen activators. Fibrinolysis 1996; 10 (suppl 2): 85-9.
32. Alam K, Arlow FL, Ma CK, Schubert TT. Decrease in ornithine decarboxylase activity after eradication of Helicobacter pylori. Am J Gastroenterol 1994; 89: 888-93.
33. Lynch DAF, Mapstone NP, Clarke AMT, Sobala GM, Jackson P, Morrison L, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995; 36: 346-50.
34. Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KEL. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994; 35: 317-22.
35. Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels; impact of eradication. Dig Dis Sci 1995; 40: 615-21.